X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (172) 172
high energy physics - experiment (171) 171
humans (76) 76
index medicus (68) 68
experiment (58) 58
particle physics (55) 55
international (54) 54
oncology (50) 50
female (48) 48
high energy physics (45) 45
male (40) 40
physics, particles & fields (40) 40
middle aged (36) 36
life sciences (35) 35
aged (32) 32
cancer (31) 31
adult (29) 29
chemotherapy (28) 28
partícules (28) 28
phenomenology (27) 27
física nuclear (25) 25
breast cancer (21) 21
prognosis (21) 21
aged, 80 and over (19) 19
disease-free survival (19) 19
lund monte-carlo (18) 18
clinical trials (17) 17
analysis (16) 16
nuclear experiment (16) 16
survival analysis (16) 16
jet fragmentation (15) 15
metastasis (15) 15
patients (15) 15
survival (15) 15
tumors (15) 15
pharmacology & pharmacy (14) 14
humanities and social sciences (13) 13
physics - high energy physics - experiment (12) 12
physics, multidisciplinary (12) 12
radiative-corrections (12) 12
retrospective studies (12) 12
simulation (12) 12
treatment outcome (12) 12
adolescent (11) 11
hematology, oncology and palliative medicine (11) 11
medicine (11) 11
particle physics - experiment (11) 11
animals (10) 10
computer science (10) 10
energies (10) 10
france (10) 10
risk (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
astronomy & astrophysics (9) 9
cancer therapies (9) 9
computer simulation (9) 9
kaplan-meier estimate (9) 9
lep (9) 9
physics, nuclear (9) 9
time factors (9) 9
breast neoplasms - mortality (8) 8
breast neoplasms - pathology (8) 8
business administration (8) 8
child (8) 8
drug administration schedule (8) 8
e+e annihilation (8) 8
medical prognosis (8) 8
metastases (8) 8
radiotherapy (8) 8
research (8) 8
research article (8) 8
therapy (8) 8
wechselwirkung (8) 8
[ sdv.can ] life sciences [q-bio]/cancer (7) 7
antineoplastic agents - administration & dosage (7) 7
care and treatment (7) 7
child, preschool (7) 7
children (7) 7
efficacy (7) 7
elektron (7) 7
follow-up studies (7) 7
health aspects (7) 7
medical research (7) 7
multivariate analysis (7) 7
neoplasm staging (7) 7
other (7) 7
pharmacokinetics (7) 7
positron (7) 7
risk factors (7) 7
trial (7) 7
young adult (7) 7
[sdv.can]life sciences [q-bio]/cancer (6) 6
algorithms (6) 6
antineoplastic agents - adverse effects (6) 6
bhabha scattering (6) 6
cell line, tumor (6) 6
e+e-physics (6) 6
genetics (6) 6
modeling and simulation (6) 6
models, biological (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 01/2020, Volume 21, Issue 1, pp. e13 - e13
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 942 - 949
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2014, Volume 135, Issue 6, p. 1307
Although the presence of nuclear estrogen receptor is widely used to guide breast cancer therapy, less attention has been paid to the receptor cytoplasmic... 
Breast cancer | Prognosis | Analysis | Estrogen | Kinases | Cancer therapies | Medical prognosis | Tumors
Journal Article
The Journal of Pathology, ISSN 0022-3417, 03/2013, Volume 229, Issue 4, pp. 546 - 558
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2007, Volume 25, Issue 9, pp. 1107 - 1113
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 4, pp. 759 - 769
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 08/2019, Volume 37, Issue 23, pp. 2008 - 2008
PURPOSENivolumab is standard of care for patients with metastatic clear cell renal cell carcinoma (ccRCC) after failure of antiangiogenic therapies, but its... 
ONCOLOGY | CANCER | MELANOMA
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2008, Volume 14, Issue 18, pp. 5907 - 5912
Purpose: Metastatic renal cancer patients with a single metastatic site are potentially amenable to interleukin 2 (IL-2) + IFN-α. A French immunotherapy... 
IFN-α | IL-2 | metastatic renal cancer | DESIGN | INTERFERON ALPHA-2A | MEDROXYPROGESTERONE | ONCOLOGY | CLINICAL-TRIALS | VINBLASTINE | DOSE INTERLEUKIN-2 | CELL CARCINOMA | CHEMOTHERAPY
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2019, Volume 30, Issue 5, pp. 757 - 765
Abstract Background Antitumor activity of molecular-targeted agents is guided by the presence of documented genomic alteration in specific histological... 
precision medicine | molecular-targeted agents | advanced cancer | decision-making | molecular profiling | MULTICENTER | GENOMICS | ONCOLOGY | MEDICINE | Life Sciences
Journal Article